This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Other lower respiratory disease
  • /
  • Safety of nintedanib added to pirfenidone treatmen...
Journal

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.

Read time: 1 mins
Published:2nd Aug 2018
Author: Flaherty KR, Fell CD, Huggins JT, Nunes H, Sussman R, Valenzuela C et al.
Availability: Free full text
Ref.:Eur Respir J. 2018;52(2). pii: 1800230.
DOI:10.1183/13993003.00230-2018
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest